| AIM2 | Absent In Melanoma 2 |
| CaMKIIδ | Calcium/Calmodulin-Dependent Protein Kinase II delta |
| CASP-1, -3/-7, 10 | Caspase-1, -3 and -7, -10 |
| CD44 | Cluster of Differentiation 44 |
| CD54 | Cluster of Differentiation 54 (ICAM-1) |
| CD105 | Cluster of Differentiation 105 |
| CEACAM1 | Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 |
| CM | Cardiomyocytes |
| CX3CL1 | C-X3-C motif chemokine ligand 1 |
| CXCL9 | C-X-C motif chemokine ligand 9 |
| CXCL11 | C-X-C motif chemokine ligand 11 |
| EC | Endothelial Cells |
| GBP4/5/6 | Guanylate Binding Protein 4, 5, 6 |
| GSDMB/D | Gasdermin B/D |
| hiPSC | Human Induced Pluripotent Stem Cell |
| ICAM-1 | Intercellular Adhesion Molecule 1 |
| ICI | Immune Checkpoint Inhibitor |
| ICI-M | Immune Checkpoint Inhibitor–induced Myocarditis |
| IFN-γ | Interferon gamma |
| IL-1β | Interleukin 1 beta |
| IL-2, 6, 18 | Interleukin 2, 6, 18 |
| IRF | Interferon Regulatory Factor |
| ITGA9 | Integrin Alpha 9 |
| JAK/STAT | Janus Kinase/Signal Transducer and Activator of Transcription |
| LAG3 | Lymphocyte-activation gene 3 |
| MAPK | Mitogen-Activated Protein Kinase |
| NF-κB | Nuclear Factor kappa-light-chain-enhancer of activated B cells |
| NLRP3 | NOD-, LRR- and pyrin domain-containing protein 3 |
| PBMC | Peripheral Blood Mononuclear Cells |
| P2X7 | Purinergic Receptor P2X, Ligand-Gated Ion Channel, 7 |
| STAT1 | Signal Transducer and Activator of Transcription 1 |
| TNF-α | Tumor Necrosis Factor alpha |
| TXNIP | Thioredoxin-interacting Protein |
| VCAM-1 | Vascular Cell Adhesion Molecule 1 |